{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T14:59:57Z","timestamp":1788447597179,"version":"build-2803163510"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03923-x","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T06:42:28Z","timestamp":1753252948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Overall survival post secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal cancer with peritoneal metastases"],"prefix":"10.1186","volume":"23","author":[{"given":"Raymond","family":"Hayler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Garrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoma","family":"Barat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Sarofim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwanthi","family":"Wijayawardana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Ahmadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Liauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"issue":"2","key":"3923_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72(2):338\u201344.","journal-title":"Gut"},{"key":"3923_CR2","doi-asserted-by":"publisher","first-page":"650098","DOI":"10.3389\/fonc.2021.650098","volume":"11","author":"O Kranenburg","year":"2021","unstructured":"Kranenburg O, van der Speeten K, de Hingh I. Peritoneal metastases from colorectal cancer: defining and addressing the challenges. Front Oncol. 2021;11:650098.","journal-title":"Front Oncol"},{"issue":"5","key":"3923_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.surge.2020.08.016","volume":"19","author":"M Flood","year":"2021","unstructured":"Flood M, Narasimhan V, Waters P, Ramsay R, Michael M, Warrier S, et al. Survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A systematic review and discussion of latest controversies. Surgeon. 2021;19(5):310\u201320.","journal-title":"Surgeon"},{"issue":"6","key":"3923_CR4","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/jso.23189","volume":"107","author":"TC Chua","year":"2013","unstructured":"Chua TC, Esquivel J, Pelz JO, Morris DL. Summary of current therapeutic options for peritoneal metastases from colorectal cancer. J Surg Oncol. 2013;107(6):566\u201373.","journal-title":"J Surg Oncol"},{"issue":"3","key":"3923_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1200\/JCO.2011.37.1039","volume":"30","author":"J Franko","year":"2012","unstructured":"Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, et al. Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of North central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol. 2012;30(3):263\u20137.","journal-title":"J Clin Oncol"},{"key":"3923_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.sopen.2024.05.018","volume":"20","author":"PH Cashin","year":"2024","unstructured":"Cashin PH, Asplund D, Bexe Lindskog E, Ghanipour L, Syk I, Graf W, et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent colorectal peritoneal metastases. Surg Open Sci. 2024;20:45\u201350.","journal-title":"Surg Open Sci"},{"issue":"8","key":"3923_CR7","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1093\/jnci\/djab001","volume":"113","author":"E Breuer","year":"2021","unstructured":"Breuer E, Hebeisen M, Schneider MA, Roth L, Pauli C, Frischer-Ordu K, et al. Site of recurrence and survival after surgery for colorectal peritoneal metastasis. JNCI: J Natl Cancer Inst. 2021;113(8):1027\u201335.","journal-title":"JNCI: J Natl Cancer Inst"},{"key":"3923_CR8","doi-asserted-by":"crossref","unstructured":"Allievi N, Sidhom M, Samuel VM, Tzivanakis A, Dayal S, Cecil T et al. Survival analysis and recurrence pattern of 519 patients with colorectal peritoneal metastases treated by cytoreductive surgery and HIPEC. Eur J Surg Oncol. 2024;50(2).","DOI":"10.1016\/j.ejso.2023.107410"},{"key":"3923_CR9","doi-asserted-by":"crossref","unstructured":"Nielsen MF, Ravn S, S\u00f8rensen MM, Funder JA, Iversen LH. Recurrence and survival following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for synchronous and metachronous peritoneal metastases of colorectal origin. Cancers (Basel). 2024;16(3).","DOI":"10.3390\/cancers16030631"},{"issue":"1","key":"3923_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s002689900560","volume":"23","author":"AG Portilla","year":"1999","unstructured":"Portilla AG, Sugarbaker PH, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg. 1999;23(1):23\u20139.","journal-title":"World J Surg"},{"issue":"12","key":"3923_CR11","doi-asserted-by":"publisher","first-page":"7809","DOI":"10.1245\/s10434-021-10093-z","volume":"28","author":"N Ahmadi","year":"2021","unstructured":"Ahmadi N, Kostadinov D, Sakata S, Ball WR, Gandhi J, Carr NJ, et al. Managing recurrent Pseudomyxoma peritonei in 430 patients after complete cytoreduction and HIPEC: A dilemma for patients and surgeons. Ann Surg Oncol. 2021;28(12):7809\u201320.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3923_CR12","doi-asserted-by":"publisher","first-page":"E71","DOI":"10.1503\/cjs.002519","volume":"63","author":"E Jost","year":"2020","unstructured":"Jost E, Mack LA, Sideris L, Dube P, Temple W, Bouchard-Fortier A. Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study. Can J Surg. 2020;63(1):E71\u20139.","journal-title":"Can J Surg"},{"issue":"3","key":"3923_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.3390\/cancers15030607","volume":"15","author":"EM Pasqual","year":"2023","unstructured":"Pasqual EM, Londero AP, Robella M, Tonello M, Sommariva A, De Simone M, et al. Repeated cytoreduction combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in selected patients affected by peritoneal metastases: Italian PSM Oncoteam evidence. Cancers. 2023;15(3):607.","journal-title":"Cancers"},{"key":"3923_CR14","doi-asserted-by":"publisher","first-page":"101572","DOI":"10.1016\/j.suronc.2021.101572","volume":"38","author":"PA Sutton","year":"2021","unstructured":"Sutton PA, O\u2019Dwyer ST, Barriuso J, Aziz O, Selvasekar CR, Renehan AG, et al. Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy. Surg Oncol. 2021;38:101572.","journal-title":"Surg Oncol"},{"issue":"1","key":"3923_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12957-024-03386-6","volume":"22","author":"M Sarofim","year":"2024","unstructured":"Sarofim M, Wijayawardana R, Ahmadi N, Morris DL. Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review. World J Surg Oncol. 2024;22(1):99.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"3923_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"PH Sugarbaker","year":"1995","unstructured":"Sugarbaker PH. Peritonectomy procedures. Ann Surg. 1995;221(1):29\u201342.","journal-title":"Ann Surg"},{"key":"3923_CR17","doi-asserted-by":"crossref","unstructured":"Jacquet P, Sugarbaker PHJP. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. 1996:359\u2013\u200974.","DOI":"10.1007\/978-1-4613-1247-5_23"},{"issue":"6","key":"3923_CR18","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1245\/s10434-022-11441-3","volume":"29","author":"CD Valenzuela","year":"2022","unstructured":"Valenzuela CD, Levine EA, Mangieri CW, Gawdi R, Moaven O, Russell G, et al. Repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for cancers with peritoneal metastasis: A 30-year institutional experience. Ann Surg Oncol. 2022;29(6):3436\u201345.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3923_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jamcollsurg.2012.04.023","volume":"215","author":"KI Votanopoulos","year":"2012","unstructured":"Votanopoulos KI, Ihemelandu C, Shen P, Stewart JH, Russell GB, Levine EA. Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. J Am Coll Surg. 2012;215(3):412\u20137.","journal-title":"J Am Coll Surg"},{"issue":"8","key":"3923_CR20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/jso.23597","volume":"109","author":"HJ Braam","year":"2014","unstructured":"Braam HJ, van Oudheusden TR, de Hingh IH, Nienhuijs SW, Boerma D, Wiezer MJ, et al. Patterns of recurrence following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. J Surg Oncol. 2014;109(8):841\u20137.","journal-title":"J Surg Oncol"},{"issue":"3","key":"3923_CR21","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/jso.25277","volume":"119","author":"NA Alzahrani","year":"2019","unstructured":"Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, et al. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience. J Surg Oncol. 2019;119(3):336\u201346.","journal-title":"J Surg Oncol"},{"key":"3923_CR22","unstructured":"Vaseghi Maghvan P, Jeibouei S, Akbari ME, Niazi V, Karami F, Rezvani A et al. Personalized medicine in colorectal cancer. Gastroenterology and hepatology from bed to bench. 2020;13(Suppl1):S18\u201328."},{"issue":"1","key":"3923_CR23","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1245\/s10434-023-14368-5","volume":"31","author":"M H\u00fcbner","year":"2024","unstructured":"H\u00fcbner M, van Der Speeten K, Govaerts K, de Hingh I, Villeneuve L, Kusamura S, et al. 2022 peritoneal surface oncology group international consensus on HIPEC regimens for peritoneal malignancies: colorectal Cancer. Ann Surg Oncol. 2024;31(1):567\u201376.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3923_CR24","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/jso.24703","volume":"116","author":"IT Konstantinidis","year":"2017","unstructured":"Konstantinidis IT, Levine EA, Chouliaras K, Russell G, Shen P, Votanopoulos KI. Interval between cytoreductions as a marker of tumor biology in selecting patients for repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. J Surg Oncol. 2017;116(6):741\u20135.","journal-title":"J Surg Oncol"},{"issue":"8","key":"3923_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ejso.2013.10.022","volume":"40","author":"BH Williams","year":"2014","unstructured":"Williams BH, Alzahrani NA, Chan DL, Chua TC, Morris DL. Repeat cytoreductive surgery (CRS) for recurrent colorectal peritoneal metastases: yes or no? Eur J Surg Oncol. 2014;40(8):943\u20139.","journal-title":"Eur J Surg Oncol"},{"key":"3923_CR26","doi-asserted-by":"crossref","unstructured":"Delpla A, de Baere T, Varin E, Deschamps F, Roux C, Tselikas L. Role of thermal ablation in colorectal Cancer lung metastases. Cancers (Basel). 2021;13(4).","DOI":"10.3390\/cancers13040908"},{"issue":"1","key":"3923_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.21037\/hbsn.2019.06.08","volume":"9","author":"H Takahashi","year":"2020","unstructured":"Takahashi H, Berber E. Role of thermal ablation in the management of colorectal liver metastasis. Hepatobiliary Surg Nutr. 2020;9(1):49\u201358.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"17suppl","key":"3923_CR28","doi-asserted-by":"publisher","first-page":"LBA3501","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA3501","volume":"42","author":"MR Meijerink","year":"2024","unstructured":"Meijerink MR, van der Lei S, Dijkstra M, Versteeg KS, Buffart TE, Lissenberg-Witte BI, et al. Surgery versus thermal ablation for small-size colorectal liver metastases (COLLISION): an international, multicenter, phase III randomized controlled trial. J Clin Oncol. 2024;42(17_suppl):LBA3501\u2013LBA.","journal-title":"J Clin Oncol"},{"issue":"2","key":"3923_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Qu\u00e9net","year":"2021","unstructured":"Qu\u00e9net F, Elias D, Roca L, Go\u00e9r\u00e9 D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(2):256\u201366.","journal-title":"Lancet Oncol"},{"key":"3923_CR30","doi-asserted-by":"crossref","unstructured":"Fisher OM, Brown C, Esquivel J, Larsen SG, Liauw W, Alzahrani NA et al. Hyperthermic intraperitoneal chemotherapy in colorectal cancer. BJS Open. 2024;8(3).","DOI":"10.1093\/bjsopen\/zrae049"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03923-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03923-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03923-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T19:51:50Z","timestamp":1757274710000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03923-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3923"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03923-x","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval was granted by the South Eastern Local Health District Ethics committee, under ethical approval code QAQI\/18\/078.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Author consent, not applicable for participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"297"}}